BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1314 related articles for article (PubMed ID: 28004626)

  • 1. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M
    CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysphoric mania, mixed states, and mania with mixed features specifier: are we mixing things up?
    McElroy SL; Keck PE
    CNS Spectr; 2017 Apr; 22(2):170-176. PubMed ID: 27866502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for bipolar disorder.
    Yatham LN
    Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?
    Faedda GL; Marangoni C
    CNS Spectr; 2017 Apr; 22(2):120-125. PubMed ID: 27831463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed features in major depressive disorder: diagnoses and treatments.
    Suppes T; Ostacher M
    CNS Spectr; 2017 Apr; 22(2):155-160. PubMed ID: 28462772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the recognition and management of mixed depression.
    Stahl SM; Morrissette DA; Faedda G; Fava M; Goldberg JF; Keck PE; Lee Y; Malhi G; Marangoni C; McElroy SL; Ostacher M; Rosenblat JD; Solé E; Suppes T; Takeshima M; Thase ME; Vieta E; Young A; Zimmerman M; McIntyre RS
    CNS Spectr; 2017 Apr; 22(2):203-219. PubMed ID: 28421980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of mixed states.
    Cuomo A; Nikolova VL; Yalin N; Arnone D; Fagiolini A; Young AH
    CNS Spectr; 2017 Apr; 22(2):186-195. PubMed ID: 28416033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
    Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
    Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Verdolini N; Hidalgo-Mazzei D; Murru A; Pacchiarotti I; Samalin L; Young AH; Vieta E; Carvalho AF
    Acta Psychiatr Scand; 2018 Sep; 138(3):196-222. PubMed ID: 29756288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of the DSM-5 mixed-features specifier of major depressive disorder.
    Zimmerman M
    CNS Spectr; 2017 Apr; 22(2):196-202. PubMed ID: 28077190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mixed features in bipolar disorder.
    Rosenblat JD; McIntyre RS
    CNS Spectr; 2017 Apr; 22(2):141-146. PubMed ID: 27618746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar II disorder : epidemiology, diagnosis and management.
    Benazzi F
    CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
    Muralidharan K; Ali M; Silveira LE; Bond DJ; Fountoulakis KN; Lam RW; Yatham LN
    J Affect Disord; 2013 Sep; 150(2):408-14. PubMed ID: 23735211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar disorders.
    McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
    Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antimanic treatments in mixed states.
    McIntyre RS; Yoon J
    Bipolar Disord; 2012 May; 14 Suppl 2():22-36. PubMed ID: 22510034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.